BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29807806)

  • 1. Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.
    Xu DR; Gong W; Gloyd S; Caine ED; Simoni J; Hughes JP; Xiao S; He W; Dai B; Lin M; Nie J; He H
    Schizophr Res; 2018 Nov; 201():307-314. PubMed ID: 29807806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation.
    Cai Y; Gong W; He W; He H; Hughes JP; Simoni J; Xiao S; Gloyd S; Lin M; Deng X; Liang Z; Dai B; Liao J; Hao Y; Xu DR
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e33628. PubMed ID: 35438649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
    Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial.
    Xu DR; Xiao S; He H; Caine ED; Gloyd S; Simoni J; Hughes JP; Nie J; Lin M; He W; Yuan Y; Gong W
    PLoS Med; 2019 Apr; 16(4):e1002785. PubMed ID: 31013275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial.
    Xu DR; Gong W; Caine ED; Xiao S; Hughes JP; Ng M; Simoni J; He H; Smith KL; Brown HS; Gloyd S
    BMJ Open; 2016 Jan; 6(1):e010120. PubMed ID: 26792221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile Texting and Lay Health Supporters to Improve Schizophrenia Care in a Resource-Poor Community in Rural China (LEAN Trial): Randomized Controlled Trial Extended Implementation.
    Cai Y; Gong W; He H; Hughes JP; Simoni J; Xiao S; Gloyd S; Lin M; Deng X; Liang Z; He W; Dai B; Liao J; Hao Y; Xu DR
    J Med Internet Res; 2020 Dec; 22(12):e22631. PubMed ID: 33258788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for measuring medication adherence in patients with schizophrenia].
    Wang Y; Huang Z; Xu D; Gong W; Tang Y; Xiao S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):218-24. PubMed ID: 26932222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Village doctor-assisted case management of rural patients with schizophrenia: protocol for a cluster randomized control trial.
    Gong W; Xu D; Zhou L; Brown HS; Smith KL; Xiao S
    Implement Sci; 2014 Jan; 9():13. PubMed ID: 24433461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia.
    El-Missiry A; Elbatrawy A; El Missiry M; Moneim DA; Ali R; Essawy H
    J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity.
    Kalichman SC; Amaral CM; Cherry C; Flanagan J; Pope H; Eaton L; Kalichman MO; Cain D; Detorio M; Caliendo A; Schinazi RF
    HIV Clin Trials; 2008; 9(5):298-308. PubMed ID: 18977718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.
    Kim J; Ozzoude M; Nakajima S; Shah P; Caravaggio F; Iwata Y; De Luca V; Graff-Guerrero A; Gerretsen P
    Neuropharmacology; 2020 May; 168():107634. PubMed ID: 31077729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among subjective and objective measures of adherence to oral antipsychotic medications.
    Velligan DI; Wang M; Diamond P; Glahn DC; Castillo D; Bendle S; Lam YW; Ereshefsky L; Miller AL
    Psychiatr Serv; 2007 Sep; 58(9):1187-92. PubMed ID: 17766564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
    Stanković Z; Ille T
    Vojnosanit Pregl; 2013 Mar; 70(3):267-73. PubMed ID: 23607237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
    Owie GO; Olotu SO; James BO
    Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.